Public health officials are concerned that we could move back into a situation like that of the early 20th century, before ...

Methicillin-resistant Staphylococcus aureus (MRSA) is a type of staph bacteria that is highly resistant to common antibiotics. Many people carry the MRSA bacteria harmlessly on their skin ...

Antibiotic treatment during an influenza infection actually impaired the body’s efforts to clear bacteria rather than helping the body heal.

MRSA is a type of staph highly resistant to a common class of antibiotics. Many people carry MRSA harmlessly on their skin or inside their noses. However, if the bacteria penetrates the skin ...

The history of antibiotic resistance in Staphylococcus aureus spans more than half a century. Methicillin-resistant S. aureus (MRSA) has emerged as an almost ubiquitous pathogen in both the ...

The US accounts for 80% to 90% of the total market for anti-MRSA antibiotics, so FDA approval is key to growing ceftobiprole's revenues, currently a minor part of its CHF 131 million ($137 million ...

This marks Zevtera as the sole FDA-approved MRSA-targeting cephalosporin antibiotic for these conditions. It is also indicated for acute bacterial skin and skin structure infections (ABSSSI ...

aureus (MRSA). The US accounts for 80% to 90% of the total market for anti-MRSA antibiotics, so FDA approval is key to growing ceftobiprole’s revenues, according to analysts. In 2023 ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported today on ...

Within a few hours, the doctor told him he had MRSA, a staph infection that is resistant to most antibiotics. From there, he ...

Scientists who developed the Oxford AstraZeneca vaccine during the Covid pandemic are developing the UK's first bubonic plague amid fears an outbreak of the disease could re-emerge.